William P. Forbes - 19 Oct 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Chief Development Officer
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
Issuer symbol
HRTX
Transactions as of
19 Oct 2025
Net transactions value
$0
Form type
4
Filing time
21 Oct 2025, 11:56:25 UTC
Previous filing
04 Aug 2025
Next filing
04 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Forbes William P EVP, Chief Development Officer 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/ Kathryn Lester Attorney-in-Fact for William P. Forbes 21 Oct 2025 0001314760

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +3,874 +2.6% 154,509 19 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -3,874 -10% $0.000000 34,869 19 Oct 2025 Common Stock 3,874 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).